The Latest Breaking News from Merck

The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — and someday even treat it.

The Health and Human Services leader made shock waves when he dismissed all 17 former members on Monday

Blue chips like MRK stock generally represent a 50/50 wager for any given week. However, certain conditions strongly tilt the odds toward one side of the spectrum.

Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, announced on March 27, 2025, to shrink its workforce by 20,000 people. Among workers dismissed in early April were several teams responsible for fulfilling requests for access to previously unreleased…

Merck & Co. will release its first-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

RFK Jr. was reportedly behind the ouster of FDA’s top vaccine official and said last week that around 10,000 employees will be laid off at the Department of Health and Human Services.

This healthcare company is down more than 30% over the past 52 weeks but still may not be a good buy for value investors.

Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

While there are short-term headwinds, Merck has a bright future ahead.